| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/19/2004 | CN1498105A Synergistic combinations of vitaminosis A receptor ligands and selected cytotoxic agents for treatment of cancer |
| 05/19/2004 | CN1496989A New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1150206C Bradykinin antagonist peptides incorporating N-substituted glycines |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150204C Cyclobornane triterpenoid saponin compound and its application in immunosuppresion and treating tumor |
| 05/19/2004 | CN1150201C L-arabino-disaccharides of anthracyclines, Process for their preparation, and pharmaceutical compositions containing them |
| 05/19/2004 | CN1150197C Naphtho- and dihydrobenzo-thiopyhene derivatives as cytotoxic antitumor agents |
| 05/19/2004 | CN1150195C Bicyclic nitrogen heterocycles |
| 05/19/2004 | CN1150189C Benzopyranone and benzodihydropyranon derivatives as integrin inhibitors |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150178C Sidechain-bearing taxanes |
| 05/19/2004 | CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them |
| 05/19/2004 | CN1150031C Use of histamine of therapeutic purposes |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/19/2004 | CN1150027C Medicine for curing tumor and its preparation method |
| 05/19/2004 | CN1150006C Beetoxin injection and its preparing process |
| 05/19/2004 | CN1150002C Antitumor compsn. contg. synergistic compsn. of anthracycline derivative with camptothecin derivate |
| 05/19/2004 | CN1149990C Cyclooxygenase-2 inhibitor for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 05/19/2004 | CN1149977C Pharmaceutical compositions in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 05/19/2004 | CN1149975C Compositions containing a peptide and polylactic-glycolic acid subitable for preparing subcutaneous implants with and extended release period |
| 05/19/2004 | CN1149971C Cosmetic or pharmaceutical compositions consisting of liposomes, its preparation method and use |
| 05/18/2004 | US6737541 Preparation of nitrogen mustard derivatives |
| 05/18/2004 | US6737534 Using 10-deacetylbaccatine iii easily recovered in large amounts from taxus baccata leaves as starting material |
| 05/18/2004 | US6737520 For use as substrate for ribonuclease and controlling binding affinity/nuclease resistance |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737441 Preventing or treating persistent chronic gastritis, ulcers and/or stomach cancer |
| 05/18/2004 | US6737439 Active cancer chemopreventative and treating agents in mammals, including humans |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737409 For cancer therapy |
| 05/18/2004 | US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737232 IAPs associated cell cycle proteins, compositions and methods of use |
| 05/18/2004 | US6737062 Immunogenic compositions |
| 05/18/2004 | US6737055 Isolated cathepsin L type cysteine proteases and reducing intercorneocyte cohesion/promoting desquamation therewith |
| 05/18/2004 | CA2225746C 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 05/13/2004 | WO2004040302A1 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |
| 05/13/2004 | WO2004039972A1 H17t213-transgenic animal, novel h17t213 protein and dna thereof |
| 05/13/2004 | WO2004039968A1 Immortalized dendritic cell line originating in bone marrow |
| 05/13/2004 | WO2004039967A1 Immortalized natural killer cell line |
| 05/13/2004 | WO2004039869A1 High-molecular weight derivatives of camptothecins |
| 05/13/2004 | WO2004039809A1 Novel quinoxaline derivatives |
| 05/13/2004 | WO2004039797A1 A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039793A1 Aminated isoflavonoid derivatives and uses thereof |
| 05/13/2004 | WO2004039782A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 05/13/2004 | WO2004039412A2 Compositions for cancer treatment |
| 05/13/2004 | WO2004039407A1 Apoptosis inducer |
| 05/13/2004 | WO2004039406A1 Medicinal preparation having chemotherapeutic encapsulated therein |
| 05/13/2004 | WO2004039398A1 Hm1.24-utilizing cancer vaccines |
| 05/13/2004 | WO2004039393A1 Anti-tumor combinations comprising proteins and chemotherapeutics |
| 05/13/2004 | WO2004039363A1 Anti-cancer composition comprising dmxaa or related compound |
| 05/13/2004 | WO2004039359A2 Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders |
| 05/13/2004 | WO2004039244A2 Methods and kits for diagnosing tumorigenicity |
| 05/13/2004 | WO2004033416A3 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004020431A3 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 05/13/2004 | WO2004014917A3 Antitumoral analogs of lamellarins |
| 05/13/2004 | WO2004002476A3 Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| 05/13/2004 | WO2003097835A3 Pharmaceutical compositions for the treatment of cancer |
| 05/13/2004 | WO2003090684B1 Polymer compositions containing a macrocyclic triene compound |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003045420A3 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 05/13/2004 | WO2003039475A8 Methods of identifying and using modulators of fractalkine receptor |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | WO2002102804A8 New use of specific cyclolignans |
| 05/13/2004 | WO2002056903A9 Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators |
| 05/13/2004 | WO2002030397A9 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 05/13/2004 | WO2002024146A9 Methods of decreasing or preventing pain using spicamycin derivatives |
| 05/13/2004 | US20040093621 Trangenic cells which generate immunoglobulins for treatment of cancer and immunological diseases |
| 05/13/2004 | US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 05/13/2004 | US20040092736 Collections of compounds |
| 05/13/2004 | US20040092724 Transmembrane mucopolysaccharide for treatment and diagnosis of cell proliferative disorders and cancer; antitumor agents |
| 05/13/2004 | US20040092709 Peptide mimics of the cytokine receptor common gamma chain and methods and compositions for making and using the same |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092584 Sensitizing cells to radiation; anticancer agents |
| 05/13/2004 | US20040092583 Treatment for inhibiting neoplastic lesions |
| 05/13/2004 | US20040092581 Ratjadone derivatives for inhibiting cell growth |
| 05/13/2004 | US20040092580 Antitumor agents; anticancer agents |
| 05/13/2004 | US20040092578 Inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 05/13/2004 | US20040092577 In situ insertion of paclitaxel; powder regenerated as injection |
| 05/13/2004 | US20040092575 Prevent insertion of peptide into cell membranes |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092562 Methods for treating inflammatory conditions or inhibiting JNK |
| 05/13/2004 | US20040092557 Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis |
| 05/13/2004 | US20040092550 Anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092549 Methods and compositions for selective cancer chemotherapy |
| 05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
| 05/13/2004 | US20040092540 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
| 05/13/2004 | US20040092535 Anticancer agents; antidiabetic agents; Alzheimer's disease; autoimmune disease |
| 05/13/2004 | US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same |
| 05/13/2004 | US20040092519 New treatment for hot flashes |